Beruflich Dokumente
Kultur Dokumente
and OP poisoning
Dr A K Dubey MD
Learning Objectives
Describe the mechanism of action of atropine.
Explain the rationale for the therapeutic use in diseases such as
COPD, Pre-anesthetic medication, salivation, and motion sickness.
Explain the rationale for the therapeutic use to produce Mydriasis
and cycloplegia.
Explain why muscarinic antagonists cause xerostomia, blurred
vision, photophobia, tachycardia, anhidrosis, difficulty in micturition,
hyperthermia, glaucoma and mental confusion in the elderly.
Explain why muscarinic antagonists are contraindicated in
glaucoma, obstructive disease of the gastrointestinal tract or urinary
tract, intestinal atony.
.
Learning Objectives
To list atropine congeners useful in refractive
error examination and mydriasis, Chronic
Obstructive Pulmonary Disease, Pre-anesthetic
medication, motion sickness, anti-spasmodic
and basis for their preference.
To predict the signs and symptoms of
Organophosphate poisoning and describe
about its management.
Important or prototypic drugs: atropine,
scopolamine, Trihexiphenidyl, Glycopyrrolate
and Ipratropium
ANTIMUSCARINIC DRUGS
alpha1
M3
CYCLOPENTOLATE 1 DAY ++
Contraindications of atropine
glaucoma
O.P. Poisoning/War Gases
Ex: Malathion, parathion, War gases
(Tabun, Sarin)
Accidental, homicidal or suicidal
poisoning
account for 80% of pesticide related
hospital admissions.
Acute intoxication results in both
muscarinic and nicotinic signs & CNS
signs.
Hypotension, increased secretions,
CNS- confusion, loss of reflexes,
convulsions, coma & central respiratory
paralysis.
Respiratory failure- primary cause of death.
Treatment
1. General supportive measures eg.
Termination of exposure, A.B.C., oxygen,
correction of shock.
2. Atropine 2-4mg IV rpt every 5-10min till
signs of atropinization i.e. increase in HR,
dilation of pupils & dryness of secretions.
3. Oximes / Cholinesterase reactivators :
pralidoxime (2-PAM), Obidoxime, diacetyl
mono-oxime (DAM)
Pralidoxime 1-2gm Iv & rpt after 20-
60min.